From 2012 to 2014, the insulin dosage market in Switzerland experienced significant growth, with year-on-year increases of 7.39%, 17.24%, and 10.6%, respectively. However, this positive trend reversed from 2015 onwards, evidenced by a continuous decline for several years. The market saw a notable drop of 26.09% in 2017 and 26.65% in 2018. Between 2019 and 2022, minor variations occurred with some stabilizing factors, but overall, there was a persistent downward trend, shown by declining values. The average annual decline over the past five years stands at -8.89%. As of 2023, the market remains in a state of contraction.
Future Trends to Watch For:
To understand the future trajectory of Switzerland's insulin dosage market, focusing on emerging trends such as advancements in insulin delivery technologies, governmental healthcare policies, and the competitive landscape among pharmaceutical companies will be essential. Additionally, monitoring the influence of new diabetes treatments and preventive healthcare measures can provide critical insights for forecasting market dynamics.
How does Switzerland rank in Insulin in Dosage Market Size Value?
| # | 24 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 China | 5,142,200,000 | 2023 | +4.22% | +3.16% | View data |
| 2 | 2 Germany | 2,490,600,000 | 2023 | -2.64% | -0.27% | View data |
| 3 | 3 United Kingdom | 1,864,000,000 | 2023 | +0.081% | +0.91% | View data |
| 4 | 4 Canada | 1,369,700,000 | 2023 | +1.89% | +2.55% | View data |
| 5 | 5 Japan | 1,340,600,000 | 2023 | -14.34% | -8.01% | View data |
| 19 | 19 Slovakia | 72,785,000 | 2023 | -0.13% | +0.52% | View data |
| 20 | 20 Ireland | 58,009,000 | 2023 | -0.15% | -0.85% | View data |
| 21 | 21 Switzerland | 53,245,000 | 2023 | -2.3% | -1.88% | |
| 22 | 22 Morocco | 42,235,000 | 2023 | +1.18% | +1.18% | View data |
| 23 | 23 Slovenia | 36,304,000 | 2023 | +0.66% | -1.13% | View data |
Latest reports
US Diabetes Market Report- Q1 2025
The US Diabetes Market in Q1 2025 is characterized by a dynamic interplay of increasing diabetes prevalence, technological advancements, and regulatory shifts. With...
China Diabetes Market Report- Q1 2025
In the first quarter of 2025, the diabetes market in China continued its dynamic expansion, influenced by significant trends in digital diabetes management,...
Japan Diabetes Market Report- Q1 2025
The Japan diabetes market in the first quarter of 2025 is experiencing dynamic changes driven by technological advancements, regulatory shifts, and strategic corporate...
Germany Diabetes Market Report- Q1 2025
The Germany Diabetes Market in the first quarter of 2025 is marked by transformative trends and strategic developments in diabetes management and treatment....
India Diabetes Market Report- Q1 2025
The diabetes market in India continues to experience significant growth in Q1 2025, driven by the rising prevalence of Type 2 diabetes. This...
UK Diabetes Market Report- Q1 2025
The diabetes market in the UK is experiencing substantial growth in Q1 2025, driven by technological advancements, increased prevalence of diabetes, and evolving...
France Diabetes Market Report- Q1 2025
In the first quarter of 2025, the diabetes market in France demonstrated significant advancements and strategic shifts, driven by key industry players and...
Canada Diabetes Market Report- Q1 2025
The Canada diabetes market in Q1 2025 is characterized by significant advancements and strategic developments across various segments. The landscape is being reshaped...
Brazil Diabetes Market Report- Q1 2025
The first quarter of 2025 has witnessed significant developments in the Diabetes market in Brazil, marked by rising prevalence and transformative shifts in...
Italy Diabetes Market Report- Q1 2025
The Italian diabetes market in the first quarter of 2025 continues to show significant growth and innovation, driven by the rising prevalence of...
